MMSI
Merit Medical Systems, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$89.60
+1.16%Year over year
Reported trailing growth
- Revenue
- +10.3%
- EBITDA
- +17.8%
- EBIT
- +17.5%
- EPS
- +20.7%
- Free cash flow
- -9.9%
- Operating cash flow
- +18.1%
Forward estimates
Based on analyst estimates
- Revenue
- +6.8%
- EBITDA
- +30.3%
- EPS
- +78.0%
Three-year CAGR
- Revenue
- +9.6%
- EBITDA
- +22.4%
- EBIT
- +28.2%
- Net income
- +19.9%
- EPS
- +18.3%
- Free cash flow
- +45.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026